Nikotiinihappo (Finnish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Nikotiinihappo" in Finnish language version.

refsWebsite

Global rank Finnish rank

14nih.gov

4^th place

12^th place

12doi.org

2^nd place

10^th place

12worldcat.org

5^th place

9^th place

2wiley.com

222^nd place

202^nd place

1web.archive.org

1^st place

1drugs.com

399^th place

2,670^th place

1duodecimlehti.fi

low place

109^th place

1acs.org

1,248^th place

1,162^nd place

1jbc.org

4,455^th place

6,374^th place

1karger.com

4,489^th place

3,260^th place

1sciencedirect.com

149^th place

237^th place

1ilo.org

1,962^nd place

429^th place

1oup.com

485^th place

642^nd place

1medscape.com

719^th place

525^th place

1ahajournals.org

3,608^th place

2,383^rd place

1ovid.com

low place

1sciencemag.org

857^th place

545^th place

acs.org

pubs.acs.org

CA Elvehjem, LJ Teply: The Structure and Estimation of Natural Products Functionally Related to Nicotinic Acid. Chemical Reviews, 1.12.1943, 33. vsk, nro 3, s. 185–208. doi:10.1021/cr60106a001 ISSN 0009-2665 Artikkelin verkkoversio.

ahajournals.org

M Linlin et al: Nicotinic Acid Activates the Capsaicin Receptor TRPV1. Arteriosclerosis, Thrombosis, and Vascular Biology, 1.6.2014, 34. vsk, nro 6, s. 1272–1280. PubMed:24675661 doi:10.1161/ATVBAHA.113.303346 Artikkelin verkkoversio.

doi.org

dx.doi.org

Scientific Opinion on the safety and efficacy of niacin (nicotinic acid and nicotinamide) as a feed additive for all animal species based on a dossier submitted by Lonza Benelux BV. EFSA Journal, heinäkuu 2012, 10. vsk, nro 7. doi:10.2903/j.efsa.2012.2788 Artikkelin verkkoversio. (Arkistoitu – Internet Archive)
W Song, GA FitzGerald: Niacin, an old drug with a new twist. Journal of Lipid Research, lokakuu 2013, 54. vsk, nro 10, s. 2586–2594. PubMed:23948546 doi:10.1194/jlr.R040592 ISSN 0022-2275 Artikkelin verkkoversio.
C Huber: Vorläufige Notiz über einige Derivate des Nicotins. Justus Liebigs Annalen der Chemie, 1867, 141. vsk, nro 2, s. 271–271. doi:10.1002/jlac.18671410218 ISSN 1099-0690 Artikkelin verkkoversio.
CA Elvehjem, LJ Teply: The Structure and Estimation of Natural Products Functionally Related to Nicotinic Acid. Chemical Reviews, 1.12.1943, 33. vsk, nro 3, s. 185–208. doi:10.1021/cr60106a001 ISSN 0009-2665 Artikkelin verkkoversio.
DJ Lanska: The discovery of niacin, biotin, and pantothenic acid. Annals of Nutrition & Metabolism, 2012, 61. vsk, nro 3, s. 246–253. PubMed:23183297 doi:10.1159/000343115 ISSN 1421-9697 Artikkelin verkkoversio.
R Altschul, A Hoffer, JD Stephen: Influence of nicotinic acid on serum cholesterol in man. Archives of Biochemistry and Biophysics, 1955, 54. vsk, nro 2, s. 558–559. PubMed:14350806 doi:10.1016/0003-9861(55)90070 ISSN 1096-0384 Artikkelin verkkoversio.
S Schandelmaier et al: Niacin for primary and secondary prevention of cardiovascular events. Cochrane Database of Systematic Reviews, 14.6.2017, nro 6. PubMed:28616955 doi:10.1002/14651858.CD009744.pub2 Artikkelin verkkoversio.
VS Kamanna, SH Ganji, ML Kashyap: The mechanism and mitigation of niacin-induced flushing. International Journal of Clinical Practice, 2009, 63. vsk, nro 9, s. 1369–1377. PubMed:19691622 doi:10.1111/j.1742-1241.2009.02099.x ISSN 1368-5031 Artikkelin verkkoversio.
I Reiche et al: Pharmacokinetics and dose recommendations of Niaspan® in chronic kidney disease and dialysis patients. Nephrology, Dialysis, Transplantation, 2011, 26. vsk, nro 1, s. 276–282. PubMed:20562093 doi:10.1093/ndt/gfq344 ISSN 1460-2385 Artikkelin verkkoversio.
M Linlin et al: Nicotinic Acid Activates the Capsaicin Receptor TRPV1. Arteriosclerosis, Thrombosis, and Vascular Biology, 1.6.2014, 34. vsk, nro 6, s. 1272–1280. PubMed:24675661 doi:10.1161/ATVBAHA.113.303346 Artikkelin verkkoversio.
S Schaffellner et al: Niacin-Associated Acute Hepatotoxicity Leading to Emergency Liver Transplantation. The American Journal of Gastroenterology, 2017, 112. vsk, nro 8, s. 1345–1346. PubMed:28766583 doi:10.1038/ajg.2017.171 ISSN 1572-0241 Artikkelin verkkoversio.
B Lauring et al: Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression. Science Translational Medicine, 22.8.2012, 4. vsk, nro 148, s. 148ra115. PubMed:22914621 doi:10.1126/scitranslmed.3003877 ISSN 1946-6242 Artikkelin verkkoversio.^{[vanhentunut linkki]}

drugs.com

Niacin Drugs.com. Viitattu 5.5.2019.

duodecimlehti.fi

N Matikainen: Suurentunut triglyseridipitoisuus. Duodecim, 2009, 125. vsk, nro 4, s. 371–380. ISSN 0012-7183 Artikkelin verkkoversio.

ilo.org

ICSC 1702 - Nikotiinihappo ilo.org.

jbc.org

CA Elvehjem et al: The Isolation and Identification of the Anti-Black Tongue Factor. Journal of Biological Chemistry, 1.3.1938, 123. vsk, nro 1, s. 137–149. ISSN 0021-9258 Artikkelin verkkoversio.

karger.com

DJ Lanska: The discovery of niacin, biotin, and pantothenic acid. Annals of Nutrition & Metabolism, 2012, 61. vsk, nro 3, s. 246–253. PubMed:23183297 doi:10.1159/000343115 ISSN 1421-9697 Artikkelin verkkoversio.

medscape.com

reference.medscape.com

vitamin B3, Niacor (niacin) dosing, indications, interactions, adverse effects, and more reference.medscape.com. Viitattu 31.5.2019.

nih.gov

pubmed.ncbi.nlm.nih.gov

W Song, GA FitzGerald: Niacin, an old drug with a new twist. Journal of Lipid Research, lokakuu 2013, 54. vsk, nro 10, s. 2586–2594. PubMed:23948546 doi:10.1194/jlr.R040592 ISSN 0022-2275 Artikkelin verkkoversio.
DJ Lanska: The discovery of niacin, biotin, and pantothenic acid. Annals of Nutrition & Metabolism, 2012, 61. vsk, nro 3, s. 246–253. PubMed:23183297 doi:10.1159/000343115 ISSN 1421-9697 Artikkelin verkkoversio.
R Altschul, A Hoffer, JD Stephen: Influence of nicotinic acid on serum cholesterol in man. Archives of Biochemistry and Biophysics, 1955, 54. vsk, nro 2, s. 558–559. PubMed:14350806 doi:10.1016/0003-9861(55)90070 ISSN 1096-0384 Artikkelin verkkoversio.
HI Kohn: The concentration of coenzyme-like substance in blood following the administration of nicotinic acid to normal individuals and pellagrins. Biochemical Journal, joulukuu 1938, 32. vsk, nro 12, s. 2075–2083. PubMed:16746848 ISSN 0264-6021 Artikkelin verkkoversio.
S Schandelmaier et al: Niacin for primary and secondary prevention of cardiovascular events. Cochrane Database of Systematic Reviews, 14.6.2017, nro 6. PubMed:28616955 doi:10.1002/14651858.CD009744.pub2 Artikkelin verkkoversio.
VS Kamanna, SH Ganji, ML Kashyap: The mechanism and mitigation of niacin-induced flushing. International Journal of Clinical Practice, 2009, 63. vsk, nro 9, s. 1369–1377. PubMed:19691622 doi:10.1111/j.1742-1241.2009.02099.x ISSN 1368-5031 Artikkelin verkkoversio.
I Reiche et al: Pharmacokinetics and dose recommendations of Niaspan® in chronic kidney disease and dialysis patients. Nephrology, Dialysis, Transplantation, 2011, 26. vsk, nro 1, s. 276–282. PubMed:20562093 doi:10.1093/ndt/gfq344 ISSN 1460-2385 Artikkelin verkkoversio.
M Linlin et al: Nicotinic Acid Activates the Capsaicin Receptor TRPV1. Arteriosclerosis, Thrombosis, and Vascular Biology, 1.6.2014, 34. vsk, nro 6, s. 1272–1280. PubMed:24675661 doi:10.1161/ATVBAHA.113.303346 Artikkelin verkkoversio.
S Schaffellner et al: Niacin-Associated Acute Hepatotoxicity Leading to Emergency Liver Transplantation. The American Journal of Gastroenterology, 2017, 112. vsk, nro 8, s. 1345–1346. PubMed:28766583 doi:10.1038/ajg.2017.171 ISSN 1572-0241 Artikkelin verkkoversio.
B Lauring et al: Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression. Science Translational Medicine, 22.8.2012, 4. vsk, nro 148, s. 148ra115. PubMed:22914621 doi:10.1126/scitranslmed.3003877 ISSN 1946-6242 Artikkelin verkkoversio.^{[vanhentunut linkki]}

ncbi.nlm.nih.gov

W Song, GA FitzGerald: Niacin, an old drug with a new twist. Journal of Lipid Research, lokakuu 2013, 54. vsk, nro 10, s. 2586–2594. PubMed:23948546 doi:10.1194/jlr.R040592 ISSN 0022-2275 Artikkelin verkkoversio.
HI Kohn: The concentration of coenzyme-like substance in blood following the administration of nicotinic acid to normal individuals and pellagrins. Biochemical Journal, joulukuu 1938, 32. vsk, nro 12, s. 2075–2083. PubMed:16746848 ISSN 0264-6021 Artikkelin verkkoversio.
S Schandelmaier et al: Niacin for primary and secondary prevention of cardiovascular events. Cochrane Database of Systematic Reviews, 14.6.2017, nro 6. PubMed:28616955 doi:10.1002/14651858.CD009744.pub2 Artikkelin verkkoversio.
VS Kamanna, SH Ganji, ML Kashyap: The mechanism and mitigation of niacin-induced flushing. International Journal of Clinical Practice, 2009, 63. vsk, nro 9, s. 1369–1377. PubMed:19691622 doi:10.1111/j.1742-1241.2009.02099.x ISSN 1368-5031 Artikkelin verkkoversio.

oup.com

academic.oup.com

I Reiche et al: Pharmacokinetics and dose recommendations of Niaspan® in chronic kidney disease and dialysis patients. Nephrology, Dialysis, Transplantation, 2011, 26. vsk, nro 1, s. 276–282. PubMed:20562093 doi:10.1093/ndt/gfq344 ISSN 1460-2385 Artikkelin verkkoversio.

ovid.com

insights.ovid.com

S Schaffellner et al: Niacin-Associated Acute Hepatotoxicity Leading to Emergency Liver Transplantation. The American Journal of Gastroenterology, 2017, 112. vsk, nro 8, s. 1345–1346. PubMed:28766583 doi:10.1038/ajg.2017.171 ISSN 1572-0241 Artikkelin verkkoversio.

sciencedirect.com

R Altschul, A Hoffer, JD Stephen: Influence of nicotinic acid on serum cholesterol in man. Archives of Biochemistry and Biophysics, 1955, 54. vsk, nro 2, s. 558–559. PubMed:14350806 doi:10.1016/0003-9861(55)90070 ISSN 1096-0384 Artikkelin verkkoversio.

sciencemag.org

stm.sciencemag.org

B Lauring et al: Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression. Science Translational Medicine, 22.8.2012, 4. vsk, nro 148, s. 148ra115. PubMed:22914621 doi:10.1126/scitranslmed.3003877 ISSN 1946-6242 Artikkelin verkkoversio.^{[vanhentunut linkki]}

web.archive.org

Scientific Opinion on the safety and efficacy of niacin (nicotinic acid and nicotinamide) as a feed additive for all animal species based on a dossier submitted by Lonza Benelux BV. EFSA Journal, heinäkuu 2012, 10. vsk, nro 7. doi:10.2903/j.efsa.2012.2788 Artikkelin verkkoversio. (Arkistoitu – Internet Archive)

wiley.com

efsa.onlinelibrary.wiley.com

Scientific Opinion on the safety and efficacy of niacin (nicotinic acid and nicotinamide) as a feed additive for all animal species based on a dossier submitted by Lonza Benelux BV. EFSA Journal, heinäkuu 2012, 10. vsk, nro 7. doi:10.2903/j.efsa.2012.2788 Artikkelin verkkoversio. (Arkistoitu – Internet Archive)

onlinelibrary.wiley.com

C Huber: Vorläufige Notiz über einige Derivate des Nicotins. Justus Liebigs Annalen der Chemie, 1867, 141. vsk, nro 2, s. 271–271. doi:10.1002/jlac.18671410218 ISSN 1099-0690 Artikkelin verkkoversio.

worldcat.org

W Song, GA FitzGerald: Niacin, an old drug with a new twist. Journal of Lipid Research, lokakuu 2013, 54. vsk, nro 10, s. 2586–2594. PubMed:23948546 doi:10.1194/jlr.R040592 ISSN 0022-2275 Artikkelin verkkoversio.
N Matikainen: Suurentunut triglyseridipitoisuus. Duodecim, 2009, 125. vsk, nro 4, s. 371–380. ISSN 0012-7183 Artikkelin verkkoversio.
C Huber: Vorläufige Notiz über einige Derivate des Nicotins. Justus Liebigs Annalen der Chemie, 1867, 141. vsk, nro 2, s. 271–271. doi:10.1002/jlac.18671410218 ISSN 1099-0690 Artikkelin verkkoversio.
CA Elvehjem, LJ Teply: The Structure and Estimation of Natural Products Functionally Related to Nicotinic Acid. Chemical Reviews, 1.12.1943, 33. vsk, nro 3, s. 185–208. doi:10.1021/cr60106a001 ISSN 0009-2665 Artikkelin verkkoversio.
CA Elvehjem et al: The Isolation and Identification of the Anti-Black Tongue Factor. Journal of Biological Chemistry, 1.3.1938, 123. vsk, nro 1, s. 137–149. ISSN 0021-9258 Artikkelin verkkoversio.
DJ Lanska: The discovery of niacin, biotin, and pantothenic acid. Annals of Nutrition & Metabolism, 2012, 61. vsk, nro 3, s. 246–253. PubMed:23183297 doi:10.1159/000343115 ISSN 1421-9697 Artikkelin verkkoversio.
R Altschul, A Hoffer, JD Stephen: Influence of nicotinic acid on serum cholesterol in man. Archives of Biochemistry and Biophysics, 1955, 54. vsk, nro 2, s. 558–559. PubMed:14350806 doi:10.1016/0003-9861(55)90070 ISSN 1096-0384 Artikkelin verkkoversio.
HI Kohn: The concentration of coenzyme-like substance in blood following the administration of nicotinic acid to normal individuals and pellagrins. Biochemical Journal, joulukuu 1938, 32. vsk, nro 12, s. 2075–2083. PubMed:16746848 ISSN 0264-6021 Artikkelin verkkoversio.
VS Kamanna, SH Ganji, ML Kashyap: The mechanism and mitigation of niacin-induced flushing. International Journal of Clinical Practice, 2009, 63. vsk, nro 9, s. 1369–1377. PubMed:19691622 doi:10.1111/j.1742-1241.2009.02099.x ISSN 1368-5031 Artikkelin verkkoversio.
I Reiche et al: Pharmacokinetics and dose recommendations of Niaspan® in chronic kidney disease and dialysis patients. Nephrology, Dialysis, Transplantation, 2011, 26. vsk, nro 1, s. 276–282. PubMed:20562093 doi:10.1093/ndt/gfq344 ISSN 1460-2385 Artikkelin verkkoversio.
S Schaffellner et al: Niacin-Associated Acute Hepatotoxicity Leading to Emergency Liver Transplantation. The American Journal of Gastroenterology, 2017, 112. vsk, nro 8, s. 1345–1346. PubMed:28766583 doi:10.1038/ajg.2017.171 ISSN 1572-0241 Artikkelin verkkoversio.
B Lauring et al: Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression. Science Translational Medicine, 22.8.2012, 4. vsk, nro 148, s. 148ra115. PubMed:22914621 doi:10.1126/scitranslmed.3003877 ISSN 1946-6242 Artikkelin verkkoversio.^{[vanhentunut linkki]}